Piper Jaffray Remains Bullish on Vanda Pharmaceuticals (VNDA) into 2016
Tweet Send to a Friend
Piper Jaffray reiterated an Overweight rating and $16.00 price target on Vanda Pharmaceuticals (NASDAQ: VNDA) following a fresh 2016 outlook ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
